10.15436/2381-0793.15.001
-
Published:2015
Issue:1
Volume:1
Page:
-
ISSN:2381-0793
-
Container-title:JOURNAL OF BIOINFORMATICS AND PROTEOMICS REVIEW
-
language:
-
Short-container-title:JBPR
Publisher
Ommega Online Publishers
Reference21 articles.
1. 1. Poynard, T., Leroy, V., Cohard, M., et al.Metaâ€analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration. (1996) Hepatology 24(4): 778- 789.
2. 2. Davis, G.L., Esteban-Mur, R., Rustgi, et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. (1998) N Engl J Med 339(21): 1493- 1499.
3. 3. McHutchison, J.G., Gordon, S.C.,Schiff, E.R., et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. (1998) N Engl J Med 339(21): 1485- 1492.
4. 4. Enomoto, N., Sakuma, I., Asahina,Y., et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. (1996) N Engl J Med 334(2): 77- 81.
5. 5. Macdonald, A., Harris, M. Hepatitis C virus NS5A: tales of a promiscuous protein. (2004) J Gen Virol85(pt9): 2485- 2502.